JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
There are no items in your shopping cart
Featured Products
Axon 2516
CAS [57333-96-7]
MF C27H44O3MW 416.64
Vitamine D receptor agonist (EC50 value 7 nM for VDR) and metabolite of vitamin D3 with a higher antitumor and lower calcemic activity as well as lower toxicity than Calcitriol. Tacalcitol inhibits proliferation and induces differentiation of keratinocytes. Tacalcitol (PRI 2191) promotes normal bone formation, and is a well-known inhibitor of chemical mediated inflammatory changes including dermal cellular infiltration and epidermal hyperplasia, used to treat T cell-mediated inflammatory skin diseases such as psoriasis, prurigo and vitiligo. PRI2191 enhances the antiproliferative effect of Imatinib (Axon 1394) on HL-60 cells.
Note: Axon 2516 is the stable monohydrate formulation of Tacalcitol
KEYWORDS: Tacalcitol | Supplier | VDR agonist | Axon Medchem | Axon 2516 | PRI 2191 | 1α | 24-Dihydroxycholecalciferol | PRI2191 | CAS [57333-96-7] [93129-94-3] | Calcitriol | VDR | Agonist | Vitamine D3 | inflammation | psoriasis | antiproliferate | antitumor | calcium | differentiation
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,5R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
[57333-96-7]
The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.
Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!
* Required Fields